Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024 NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving...

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021 NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear Shareholders, In the context of the Covid-19 pandemic and in accordance with Ordinance no....

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020 NEW YORK, June 29, 2020 (GLOBE NEWSWIRE) -- Cellectis S.A. held its Annual Shareholders’ General Meeting (Euronext Growth: ALCLS – Nasdaq: CLLS) on June 29, 2020 at its head office in Paris, France....

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 29, 2020 NEW YORK, May 11, 2020 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS). Dear Shareholders, In the context of the COVID-19 epidemic and in accordance with Ordinance No....